MedTrace Logo

European Carto® XP REgistry for Validating Specialized CFAE SOftware

NCT00812916 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2016-02-08

Study results available
· View outcomes & findings →

Summary

The purpose of this prospective observational study (registry) is to determine the acute success rate of a complex fractionated atrial electrogram (CFAE) guided ablation procedure using a dedicated software and to determine the functionality and performance of the CFAE software in patients with a type of persistent atrial fibrillation (AF) in routine clinical practice.

Conditions

Interventions

PROCEDURE

RF ablation, using specialized CFAE software

RF ablation

Sponsors & Collaborators

  • Biosense Webster EMEA

    lead INDUSTRY

Principal Investigators

  • Jean-Paul Albenque, MD · Clinique Pasteur - Unité de Cardiologie interventionnelle

  • Agustin Bortone, MD · Hôpital Les Franciscaines Service Rhythmologie,

  • André Pisapia, MD · Hôpital Saint Joseph

  • Franck Raczka, MD · CHU Arnaud de Villeneuve

  • Csaba Földesi, MD · Gottsegen György Országos Kardiológiai Intézet

  • Armin Luik, MD · Städtisches Klinikum Karlsruhe

  • Boris Schmidt, MD · Asklepios Klinik St. Georg

  • Ahmed Abdelaal, MD · Central Hospital, Nancy, France

  • Gilles-Sélim Lande-Abbey, MD · Hôpital Laënnec - CHU de Nantes

  • Bruno Cauchemez, MD · Clinique Ambroise Paré

  • Nicolas Lellouche, MD · Henri Mondor University Hospital

  • Fabrice Extramiana, MD · Hôpital Lariboisière Service de Rhytmologie

  • Julien Seitz, MD · Hôpital Privé Jacques Cartier Service de Rhytmologie

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-09-30
Completion
2010-12-31

Countries

  • France
  • Germany
  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00812916 on ClinicalTrials.gov